Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-06-24
    E.g., 2018-06-24

Articles

Pages

51061 items
2:39 PM, Jun 23, 2018  |  BC Extra | Financial News

Latest batch of IPO filings: Rubius, Constellation, Replimune, Allakos

As a busy week for IPO pricings came to a close, several more companies filed for NASDAQ listings late Friday, further stocking an IPO pipeline of companies likely to seek liquidity during a tight calendar...
4:44 PM, Jun 22, 2018  |  BC Extra | Company News

Roche taps gRED’s Sabry as global head of partnering

A newly created global head of partnering role at Roche (SIX:ROG; OTCQX:RHHBY) is set to combine the pharma’s partnering functions for the first time since it completed its acquisition of Genentech Inc. James Sabry, head...
4:16 PM, Jun 22, 2018  |  BC Extra | Company News

FDA cracks down on missing postmarket trial

FDA determined the Perrigo Israel Pharmaceuticals Ltd. unit of Perrigo Co. plc (NYSE:PRGO; Tel Aviv:PRGO) has failed to comply with a postmarketing trial requirement to assess the risk of major cardiovascular events (MACE) associated with...
4:01 PM, Jun 22, 2018  |  BC Extra | Preclinical News

Alzheimer's disease linked to herpesvirus

Researchers from the Icahn School of Medicine at Mount Sinai and colleagues found traces of mild strains of herpesvirus in the brains of patients with Alzheimer's disease, adding evidence to previous theories that some viruses...
3:55 PM, Jun 22, 2018  |  BC Extra | Preclinical News

Blocking LSD1 could activate cancer immune response via HERV

A Harvard Medical School team led by immunology and pathology professor Arlene Sharpe has shown inhibiting lysine-specific demethylase (LSD1; KDM1A) increases human endogenous retrovirus (HERV) transcription to activate an immune response that could help treat...
3:48 PM, Jun 22, 2018  |  BC Extra | Politics & Policy

FDA lays out cancer PRO strategy

FDA staff set out the agency’s thinking and progress in developing a standard approach to assessing patient reported outcomes (PROs) at a workshop Friday to discuss clinical outcome assessments in cancer trials. The joint FDA-American...
3:16 PM, Jun 22, 2018  |  BC Extra | Politics & Policy

House passes sweeping opioid legislation

The House of Representatives passed a broad bipartisan measure Friday to combat the opioid crisis by a vote of 396-14. The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities...
3:11 PM, Jun 22, 2018  |  BC Extra | Financial News

Crinetics proposes $86.3M IPO

Endocrine disease company Crinetics Pharmaceuticals Inc. (San Diego, Calif.) proposed to raise up to $86.3 million in an IPO on NASDAQ underwritten by J.P. Morgan, Leerink and Piper Jaffray. In March, Crinetics raised a $63.5 million...
2:22 PM, Jun 22, 2018  |  BC Extra | Politics & Policy

China accelerates drug review timelines for rare, life-threatening diseases

The China State Council set new policies to speed drug approvals, accelerate price cuts and market access for cancer drugs, and monitor and increase drug supplies. The changes include setting a review timeline of three months...
7:56 PM, Jun 21, 2018  |  BC Extra | Financial News

First-day bump for Autolus after pricing $150M IPO

Autolus Therapeutics plc (NASDAQ:AUTL) climbed $8 (47%) to $25 its first day of trading Friday after it raised $150 million via the sale of 8.8 million ADSs at $17 in an upsized IPO. Underwriters are...

Pages